Study of JP-1366 for heartburn and acid reflux
Part of Digestive system clinical trials.
This trial tests a new medicine, JP-1366, for people with non-erosive GERD (heartburn and acid reflux without visible damage to the esophagus). The goal is to see if it helps control symptoms better than a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heartburn and acid regurgitation (stomach acid or food coming back up).
- An upper endoscopy (camera test) showed no damage to the lining of your esophagus.
- You do not have H. pylori (a stomach bacteria) infection.
- You have not had major stomach or esophagus surgery or conditions.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, JP-1366, for people with reflux esophagitis (damage to the esophagus from stomach acid). It aims to see if the drug is safe and effective at healing the esophagus and relieving symptoms like heartburn and regurgitation.
This trial tests a new medicine (JP-1366) to see if it can keep the esophagus healed in people who have been treated for erosive esophagitis. You may join if you are an adult with healed erosive esophagitis and have taken standard acid-blocking medication for at least 4 weeks.
This trial tests a new drug called JP-1366 to see if it can prevent stomach ulcers caused by long-term NSAID use (like ibuprofen or naproxen) for conditions such as arthritis. It may be a good fit if you need to take NSAIDs for at least 24 weeks and have a higher risk of ulcers.
This study tests a new topical treatment for people with chronic heartburn and acid regurgitation who don't have erosions (damage) in their esophagus. The treatment is applied directly to the affected area and may help relieve symptoms without taking daily pills.
This trial tests a new way to treat GERD (chronic acid reflux) using a tiny camera and a device that delivers a gentle heat treatment (argon plasma coagulation) to the area where the stomach meets the esophagus. It's compared to a 'sham' procedure (you won't know which you get) to see if it stops acid from backing up better than medicine alone.
This study tests a new procedure called anti-reflux mucosal ablation to see if it helps people with long-lasting heartburn and acid reflux. It might be an option if medications haven't fully controlled your symptoms.
Hear when a new Non-erosive Gastroesophageal Reflux Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.